Your Article Summary
Novartis announces typhoid vaccine research program in partnership with the Wellcome Trust
Novartis, 06/05/09
Novartis announced that the Novartis Vaccines Institute for Global Health (NVGH) has been awarded a grant from the Wellcome Trust to develop a bivalent vaccine for Typhoid fever, a disease that affects more than 21 million people worldwide every year.
Today in M&A/Partnerships...keeping you current
Receive free subspecialty "5-minute updates" via email
Omnicell Gets Cabinet Deal in Carolinas
HealthDataManagement, 12/16/09
Array BioPharma and Amgen Partner in Type 2 Diabetes
Amgen, 12/15/09
Inno Biologics and CEVEC Sign License Agreement for Human CAP Technology
b3c newswire, 12/09/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
AstraZeneca and the University of Virginia sign strategic research collaboration to develop novel treatments for cardiovascular disease
AstraZeneca, 12/16/09
Sanofi Pasteur expands study of vaccine against Clostridium difficile into the U.S.
Sanofi-aventis, 12/16/09
Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study
Amylin Pharmaceuticals, 12/16/09
Article Search
Sponsor


See Latest Articles


